# Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections

> **NCT06843668** · PHASE2,PHASE3 · RECRUITING · sponsor: **Mansoura University** · enrollment: 120 (estimated)

## Conditions studied

- Critical Ill Patients
- Multi Drug Resistant

## Interventions

- **DRUG:** EMA colistin dosing strategy
- **DRUG:** US FDA colistin dosing strategy

## Key facts

- **NCT ID:** NCT06843668
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-25
- **Primary completion:** 2025-09-25
- **Final completion:** 2025-10-25
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06843668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06843668, "Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06843668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*